Developing and Validating an LDT for IDH1/2 Mutations and MGMT Methylation

被引：0
|
作者：
Hudzik, C. [1 ]
Yan, L. [1 ]
机构：
[1] EpigenDx Inc, Hopkinton, MA USA
来源：
JOURNAL OF MOLECULAR DIAGNOSTICS | 2024年 / 26卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
G041
引用
收藏
页码：S12 / S13
页数：2
相关论文
共 50 条
  • [1] Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
    Mahmoud, Magda Sayed
    Khalifa, Mohamed K.
    Nageeb, Amira M.
    El-Arab, Lobna R. Ezz
    El-Mahdy, Manal
    Ramadan, Amal
    Hashim, Maha
    Bakr, Noha M.
    Swellam, Menha
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2024, 25 (01)
  • [2] Clinical impact of IDH1 mutations and MGMT methylation in adult glioblastoma
    Magda Sayed Mahmoud
    Mohamed K. Khalifa
    Amira M. Nageeb
    Lobna R. Ezz El-Arab
    Manal El-Mahdy
    Amal Ramadan
    Maha Hashim
    Noha M. Bakr
    Menha Swellam
    Egyptian Journal of Medical Human Genetics, 25
  • [3] The combination of IDH1 mutations and MGMT methylation status predicts survival in glioblastoma better than either IDH1 or MGMT alone
    Molenaar, Remco J.
    Verbaan, Dagmar
    Lamba, Simona
    Zanon, Carlo
    Jeuken, Judith W. M.
    Boots-Sprenger, Sandra H. E.
    Wesseling, Pieter
    Hulsebos, Theo J. M.
    Troost, Dirk
    van Tilborg, Angela A.
    Leenstra, Sieger
    Vandertop, W. Peter
    Bardelli, Alberto
    van Noorden, Cornelis J. F.
    Bleeker, Fonnet E.
    NEURO-ONCOLOGY, 2014, 16 (09) : 1263 - 1273
  • [4] Molecular analysis of IDH1/2 mutations and MGMT promoter methylation in gliomas and meningiomas
    Saetta, A.
    Gioti, A.
    Chatziandreou, I.
    Tsioli, P.
    Soldatos, R. F.
    Sakellariou, S.
    Samaras, V.
    Sepsa, A.
    Zisakis, A.
    Korkolopoulou, P.
    Patsouris, E.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 319 - 319
  • [5] The Next Generation of Glioma Biomarkers: MGMT Methylation, BRAF Fusions and IDH1 Mutations
    von Deimling, Andreas
    Korshunov, Andrey
    Hartmann, Christian
    BRAIN PATHOLOGY, 2011, 21 (01) : 74 - 87
  • [6] MGMT Methylation is Strongly Associated with and May Precede IDH1/IDH2 Mutations in Adult Astrocytic and Oligodendroglial Tumours
    Mulholland, S. A.
    Malley, D. S.
    Hamoudi, R.
    Kocialkowski, S.
    Pearson, D.
    Collins, V. P.
    Ichimura, K.
    JOURNAL OF PATHOLOGY, 2011, 224 : S13 - S13
  • [7] PROGNOSTIC OR PREDICTIVE VALUE OF MGMT PROMOTER METHYLATION IN MALIGNANT GLIOMAS DEPENDS ON IDH1 MUTATIONS
    Wick, W.
    Meisner, C.
    Hentschel, B.
    Platten, M.
    Sabel, M.
    Koeppen, S.
    Ketter, R.
    Simon, M.
    Reifenberger, G.
    Weller, M.
    NEURO-ONCOLOGY, 2012, 14 : 7 - 7
  • [8] Glioblastomas: IDH1/2 Mutations and Their Correlation with MGMT Gene Promoter Methylation, a Tertiary Cancer Centre Experience
    Khirwal, K.
    Gurav, M.
    Gogte, P.
    Rumde, R.
    Rail, K.
    Kadam, V.
    Sahay, A.
    Shetty, O.
    Eparil, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : S58 - S59
  • [9] MGMT METHYLATION, BRAF AND IDH1/2 MUTATIONS AND EGFR VARIANT III DETECTION AND THEIR ASSOCIATION WITH BEVACIZUMAB TREATMENT
    Rigakos, Georgios
    Spyri, Olympia
    Nomikos, Pau
    Stavridi, Flora
    Grossi, Irene
    Theodorakopoulou, Ioanna
    Assi, Avraam
    Kouvatseas, Georgios
    Papadopoulou, Eirini
    Nasioulas, Georgios
    Labropoulos, Stefanos
    Razis, Evangelia
    NEURO-ONCOLOGY, 2013, 15 : 72 - 72
  • [10] SOCS1 Methylation is Associated to MGMT Methylation and IDH1 Mutation in Gliomas
    Irles Vidal, E.
    Alenda, C.
    Egoavil, C.
    Garcia-Martinez, A.
    Hernandez-Illan, E.
    Martinez-Canto, A.
    Castillejo, M. I.
    Quintanar, T.
    Castillejo, A.
    Barbera, V. M.
    EUROPEAN JOURNAL OF CANCER, 2012, 48 : S136 - S136
12345